ebanga 400 MG Injection
- RxCUI
- 2472161
- RxNorm name
- ebanga 400 MG Injection
- Display name
- ebanga 400 MG Injection
- Full name
- ebanga 400 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:10
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761172 | Ebanga | ansuvimab-zykl | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ebanga | ANSUVIMAB | Emergent BioDefense Operations Lansing LLC | de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5 | 2026-08-13 | Warnings, Adverse reactions | 2472161 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 9c008384-379d-48d3-b5a5-9809ed0f655c | ebanga 400 MG Injection [PSN] · ansuvimab-zykl 400 MG Injection [Ebanga] [SBD] · Ebanga 400 MG Injection [SY] | 3 | 5 | These highlights do not include all the information needed to use EBANGA™ safely and effectively. See full prescribing information for EBANGA. EBANGA (ansuvimab-zykl) for injection, for intravenous use Initial U.S. Approval: 2020 | 20250210 |
| de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5 | ebanga 400 MG Injection [PSN] · ansuvimab-zykl 400 MG Injection [Ebanga] [SBD] · Ebanga 400 MG Injection [SY] | 3 | 2 | These highlights do not include all the information needed to use EBANGA™ safely and effectively. See full prescribing information for EBANGA. EBANGA TM (ansuvimab-zykl) for injection, for intravenous use Initial U.S. Approval: 2020 | 20260220 |